NEW YORK, Feb 8, 2026, 14:42 EST — The market is shut.
- Philip Morris ended the session at $182.81, up 0.45%, following its earnings and outlook update.
- Zyn nicotine pouches delivered a bump in volumes, though promotions and competition remained front and center.
- Eyes now turn to Monday’s open for any follow-through, with April’s next earnings checkpoint already on the radar.
Philip Morris International finished Friday’s session at $182.81, up 0.45%, as the market weighed fresh quarterly numbers and the company’s 2026 guidance before trading picks up again Monday.
Markets are closed Sunday. The immediate question: will the stock keep its post-results gains, or will fresh chatter about stiffer competition in nicotine pouches shove costs and margins back into the spotlight?
Smoke-free products now sit at the heart of the bullish argument for the company. Every Zyn pouch and IQOS heated tobacco update lands with extra weight—price cuts and promos show up in the figures, and investors react.
PMI booked adjusted earnings of $1.70 per share for the fourth quarter, on net revenues totaling $10.36 billion, the company reported Friday. For 2026, PMI is targeting adjusted EPS between $8.38 and $8.53, alongside an “organic” net revenue growth estimate of 5% to 7%—a figure that strips out currency swings and M&A impacts. First-quarter adjusted profit is pegged at $1.80 to $1.85 a share. CEO Jacek Olczak put full-year net revenues above $40 billion, “including close to $17 billion from our smoke-free business.” Zyn’s quarterly shipment volume? 196 million cans, up more than 19%. pmi.com
But the nicotine-pouch narrative for the company has hit some twists. According to Reuters, PMI investors have been on edge as competitors like British American Tobacco make strides in the pouch segment. CEO Olczak said PMI stands ready to roll out new Zyn versions, though that depends on getting regulatory green lights. Jefferies’ Andrei Andon-Ionita described PMI’s latest targets as a “reassuring outlook” despite the heated rivalry. Reuters
The action on Friday underscored the back-and-forth: shares swung from $178.00 up to $186.55, finally closing at $182.81. Volume landed at roughly 8.6 million shares.
PMI submitted its earnings release to the SEC on Form 8-K, dated Feb. 6, according to a filing.
The risks are easy enough to spot. Heavier discounting or ramped-up promos to protect pouch share might squeeze margins, and any rollout of new products or expansion is still on hold while regulators in major markets take their time.
All eyes now shift to April 21, when the company will post Q1 results. Investors are expected to zero in on U.S. pouch volumes, pricing strategy, and what it’s taking to maintain market share.
